secwatch.observer — SEC 8-K summary
======================================

Issuer:     ArriVent BioPharma, Inc. (AVBP)
CIK:        0001868279
Form:       8-K
Filed at:   2026-06-22T20:01:26+00:00
Accession:  0001104659-26-076352
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

ArriVent BioPharma announces 2026 annual meeting voting results; directors elected, auditor ratified
--------------------------------------------------------------------------------

- Stockholders elected James Healy, John Hohneker, and Stuart Lutzker as Class II directors for three-year terms.
- Healy received 18,058,285 votes for; Hohneker 28,043,164; Lutzker 29,495,923; broker non-votes 3,832,858 each.
- Ratification of PricewaterhouseCoopers LLP as auditor for FY 2026 passed with 33,411,773 votes for, 829 against.
- Quorum of 33,418,793 shares (72.07% of eligible) was present at the meeting.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/0001104659-26-076352-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1868279/000110465926076352/tm2618466d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-26-076352

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer